Literature DB >> 32097185

Potential Biomarkers for Allergic Conjunctival Diseases.

Neeta Roy1, Shir Levanon, Penny A Asbell.   

Abstract

Allergic conjunctival diseases (ACDs) are a group of ocular allergies that include allergic conjunctivitis, atopic keratoconjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis. Although a large body of information exists on the pathophysiology of ACDs, this has not yet lead to the development of clear recommendations and guidelines for the diagnosis of ACDs or development of conclusive and objective diagnostic tools. Identification of objectively measurable biomarkers that represent the molecular and cellular mechanisms associated with ACDs will be an important step toward achieving these aims. This is a comprehensive review of biological markers that have the potential to become "biomarker(s)" for ACDs and aid in the classification, diagnosis, and development of new therapeutic strategies for these group of allergic conditions.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32097185      PMCID: PMC7122043          DOI: 10.1097/ICL.0000000000000688

Source DB:  PubMed          Journal:  Eye Contact Lens        ISSN: 1542-2321            Impact factor:   3.152


  121 in total

1.  Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage.

Authors:  K Fukagawa; T Nakajima; K Tsubota; S Shimmura; H Saito; K Hirai
Journal:  J Allergy Clin Immunol       Date:  1999-06       Impact factor: 10.793

2.  Cell type-dependent effects of corticosteroid on periostin production by primary human tissue cells.

Authors:  T Shoda; K Futamura; F Kobayashi; H Saito; K Matsumoto; A Matsuda
Journal:  Allergy       Date:  2013-10-10       Impact factor: 13.146

3.  Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.

Authors:  A Leonardi; F Borghesan; D Faggian; M Depaoli; A G Secchi; M Plebani
Journal:  Am J Ophthalmol       Date:  2000-02       Impact factor: 5.258

4.  The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases.

Authors:  Hiroshi Fujishima; Naoko Okada; Kenji Matsumoto; Kazumi Fukagawa; Ayako Igarashi; Akio Matsuda; Junya Ono; Shoichiro Ohta; Hideki Mukai; Mamoru Yoshikawa; Kenji Izuhara
Journal:  J Allergy Clin Immunol       Date:  2016-03-07       Impact factor: 10.793

5.  No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis.

Authors:  E Nivenius; P G Montan; E Chryssanthou; K Jung; M van Hage-Hamsten; I van der Ploeg
Journal:  Clin Exp Allergy       Date:  2004-05       Impact factor: 5.018

Review 6.  Functions of ocular surface mucins in health and disease.

Authors:  Flavio Mantelli; Pablo Argüeso
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-10

7.  Concentration of soluble interleukin-6 receptors in tears of allergic conjunctival disease patients.

Authors:  Jun Shoji; Atsuri Kawaguchi; Aki Gotoh; Noriko Inada; Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2007-10-05       Impact factor: 2.447

Review 8.  The ocular surface: from physiology to the ocular allergic diseases.

Authors:  Jorge Galicia-Carreón; Concepción Santacruz; Enrique Hong; María C Jiménez-Martínez
Journal:  Rev Alerg Mex       Date:  2013 Oct-Dec

Review 9.  Neuropathic Pain and Itch Mechanisms Underlying Allergic Conjunctivitis.

Authors:  Merin Kuruvilla; Jerry Kalangara; F. Eun-Hyung Lee
Journal:  J Investig Allergol Clin Immunol       Date:  2018-09-17       Impact factor: 4.333

Review 10.  Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease.

Authors:  José L Reyes; Danielle T Vannan; Bertus Eksteen; Imelda Juárez Avelar; Tonathiu Rodríguez; Marisol Ibet González; Alicia Vázquez Mendoza
Journal:  Mediators Inflamm       Date:  2018-08-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.